Escitalopram and QTc Interval Prolongation

Introduction to QTc Effects

Escitalopram can prolong the QTc interval, although it generally poses less risk compared to other psychotropic medications such as tricyclic antidepressants, according to the European Heart Journal 1

Concomitant use of other QT-prolonging medications is a clinical risk factor for QTc prolongation with escitalopram, as noted by the European Heart Journal 1
Electrolyte abnormalities, particularly hypokalemia, are also a risk factor for QTc prolongation with escitalopram, as reported by the European Heart Journal 2

The European Heart Journal recommends obtaining a baseline ECG before initiating escitalopram, especially in patients with cardiac risk factors 2
Evaluation of the QT interval before treatment initiation and during dose titration is recommended by the European Heart Journal 2
If the QTc reaches >500 ms or increases by >60 ms compared to baseline, treatment should be discontinued or the dose reduced, according to expert consensus reported by the European Heart Journal 2
Avoiding concomitant treatment with other medications known to prolong the QTc interval when possible is advised by the European Heart Journal 2
Maintaining normal potassium levels during treatment is recommended by the European Heart Journal 2

Exercise greater caution in elderly patients when prescribing escitalopram, as recommended by the European Heart Journal 2
Patients with pre-existing cardiac conditions require closer monitoring when taking escitalopram, according to the European Heart Journal 2
Consider referral to a cardiologist in cases of structural heart disease, QT prolongation, or cardiac symptoms, as suggested by the European Heart Journal 2